Sucampo Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/19/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Medifast launches Trilivy, replacing its Optavia brand
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
Sucampo Pharma (SCMP) Tops Q2 EPS by 1c; Reiterates 2017 Guidance
August 2, 2017 6:34 AM EDTSucampo Pharma (NASDAQ: SCMP) reported Q2 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $59.9 million versus the consensus estimate of $56.43 million.
Guidance
Sucampo today reiterated its guidance for the full year ending December 31, 2017. Sucampo... More
